CAI:MCRO (Egypt)
Â
E£
1.52
-0.040 (-2.56%)
Aug 24
Business Description
Macro Group Pharmaceuticals (Macro Capital) Co
ISIN : EGS7D971C011
Total Employee Number:
936Compare
Compare
Traded in other countries / regions
MCRO.Egypt IPO Date
2022-02-10Description
Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 11.05 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | 0.27 | |||||
Interest Coverage | 6.4 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 10.36 | |||||
Beneish M-Score | -1.43 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 24.59 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 37.83 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.12 | |||||
9-Day RSI | 51.88 | |||||
14-Day RSI | 54.98 | |||||
3-1 Month Momentum % | 17.74 | |||||
6-1 Month Momentum % | 2.1 | |||||
12-1 Month Momentum % | 223.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.97 | |||||
Quick Ratio | 2.57 | |||||
Cash Ratio | 1.37 | |||||
Days Inventory | 175.36 | |||||
Days Sales Outstanding | 48.1 | |||||
Days Payable | 128.46 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 70.14 | |||||
Operating Margin % | 16.7 | |||||
Net Margin % | 14.99 | |||||
EBITDA Margin % | 20.91 | |||||
FCF Margin % | -2.64 | |||||
OCF Margin % | -1.76 | |||||
ROE % | 37.45 | |||||
ROA % | 13.66 | |||||
ROIC % | 23.74 | |||||
ROC (Joel Greenblatt) % | 165.14 | |||||
ROCE % | 34.35 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 25.76 | |||||
Forward PE Ratio | 26 | |||||
PE Ratio without NRI | 25.76 | |||||
PS Ratio | 4.29 | |||||
PB Ratio | 6.52 | |||||
Price-to-Tangible-Book | 6.61 | |||||
EV-to-EBIT | 32.71 | |||||
EV-to-EBITDA | 29.76 | |||||
EV-to-Forward-EBITDA | 4.41 | |||||
EV-to-Revenue | 6.22 | |||||
EV-to-Forward-Revenue | 1.54 | |||||
EV-to-FCF | -235.42 | |||||
Price-to-Graham-Number | 2.58 | |||||
| Price-to-Net-Current-Asset-Value | 8 | |||||
| Price-to-Net-Cash | 50.67 | |||||
Earnings Yield (Greenblatt) % | 3.06 | |||||
FCF Yield % | -0.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Macro Group Pharmaceuticals (Macro Capital) Co Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil E£) | 766.136 | ||
| EPS (TTM) (E£) | 0.059 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.7 | ||
| 3-Year Sortino Ratio | 1.69 | ||
| Volatility % | 87.67 | ||
| 14-Day RSI | 54.98 | ||
| 14-Day ATR (E£) | 0.065207 | ||
| 20-Day SMA (E£) | 1.523 | ||
| 12-1 Month Momentum % | 223.38 | ||
| 52-Week Range (E£) | 0.453662 - 1.74 | ||
| Shares Outstanding (Mil) | 3,421.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Macro Group Pharmaceuticals (Macro Capital) Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Macro Group Pharmaceuticals (Macro Capital) Co Stock Events
| Event | Date | Price (E£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Macro Group Pharmaceuticals (Macro Capital) Co Frequently Asked Questions
What is Macro Group Pharmaceuticals (Macro Capital) Co(CAI:MCRO)'s stock price today?
The current price of CAI:MCRO is E£1.52. The 52 week high of CAI:MCRO is E£1.74 and 52 week low is E£0.45.
When is next earnings date of Macro Group Pharmaceuticals (Macro Capital) Co(CAI:MCRO)?
The next earnings date of Macro Group Pharmaceuticals (Macro Capital) Co(CAI:MCRO) is .
Does Macro Group Pharmaceuticals (Macro Capital) Co(CAI:MCRO) pay dividends? If so, how much?
Macro Group Pharmaceuticals (Macro Capital) Co(CAI:MCRO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Macro Group Pharmaceuticals (Macro Capital) Co
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers